Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Luca Miele, Antonio Lanzone, Maurizio Pompili, Rosanna Apa, Francesca Sagnella, Daniela Martinez, Francesca Moro, Andrea Morciano, Consuelo Cefalo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

31 Citazioni (Scopus)

Abstract

The objective of this study is to determine the ability of metformin treatment in reducing the prevalence of metabolic syndrome (MS) and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome (PCOS).
Lingua originaleEnglish
pagine (da-a)520-527
Numero di pagine8
RivistaClinical Endocrinology
Volume75
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Female
  • Humans
  • Hyperinsulinism
  • Hypoglycemic Agents
  • Liver
  • Metabolic Syndrome X
  • Metformin
  • Overweight
  • Polycystic Ovary Syndrome
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Insieme formano una fingerprint unica.

Cita questo